INGN – Inogen Inc.
INGN — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
4.86
Margin Of Safety %
Put/Call OI Ratio
0.08
EPS Next Q Diff
0.23
EPS Last/This Y
0.34
EPS This/Next Y
0.21
Price
6.81
Target Price
12.67
Analyst Recom
1
Performance Q
2.26
Upside
-542.6%
Beta
1.63
Ticker: INGN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | INGN | 6.36 | 0.12 | 0.00 | 1033 |
| 2026-03-10 | INGN | 6.23 | 0.12 | 0.00 | 1015 |
| 2026-03-11 | INGN | 6.22 | 0.12 | 0.00 | 1017 |
| 2026-03-12 | INGN | 6.11 | 0.12 | 0.00 | 1017 |
| 2026-03-13 | INGN | 6.1 | 0.12 | 0.00 | 1017 |
| 2026-03-17 | INGN | 6.2 | 0.12 | 0.00 | 1015 |
| 2026-03-18 | INGN | 6.12 | 0.12 | 0.00 | 1015 |
| 2026-03-19 | INGN | 6.14 | 0.10 | 0.00 | 1062 |
| 2026-03-20 | INGN | 6.09 | 0.09 | 0.00 | 1056 |
| 2026-03-23 | INGN | 6.44 | 0.06 | 0.69 | 603 |
| 2026-03-24 | INGN | 6.33 | 0.06 | 0.69 | 603 |
| 2026-03-25 | INGN | 6.41 | 0.08 | 0.00 | 609 |
| 2026-03-26 | INGN | 6.49 | 0.08 | 0.00 | 609 |
| 2026-03-27 | INGN | 6.19 | 0.08 | 0.00 | 613 |
| 2026-03-30 | INGN | 6.12 | 0.08 | 0.07 | 614 |
| 2026-03-31 | INGN | 6.18 | 0.08 | 0.07 | 614 |
| 2026-04-01 | INGN | 6.26 | 0.08 | 0.00 | 638 |
| 2026-04-02 | INGN | 6.22 | 0.08 | 0.00 | 638 |
| 2026-04-06 | INGN | 6.49 | 0.08 | 0.30 | 638 |
| 2026-04-07 | INGN | 6.81 | 0.08 | 0.30 | 638 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | INGN | 6.37 | -90.9 | - | -0.52 |
| 2026-03-10 | INGN | 6.24 | -90.9 | - | -0.52 |
| 2026-03-11 | INGN | 6.23 | -90.9 | - | -0.52 |
| 2026-03-12 | INGN | 6.11 | -90.9 | - | -0.52 |
| 2026-03-13 | INGN | 6.07 | -90.9 | - | -0.52 |
| 2026-03-17 | INGN | 6.20 | -90.9 | - | -0.52 |
| 2026-03-18 | INGN | 6.13 | -90.9 | - | -0.52 |
| 2026-03-19 | INGN | 6.14 | -90.9 | - | -0.52 |
| 2026-03-20 | INGN | 6.10 | -90.9 | - | -0.52 |
| 2026-03-23 | INGN | 6.44 | -90.9 | - | -0.52 |
| 2026-03-24 | INGN | 6.32 | -90.9 | - | -0.52 |
| 2026-03-25 | INGN | 6.43 | -90.9 | - | -0.52 |
| 2026-03-26 | INGN | 6.50 | -90.9 | - | -0.52 |
| 2026-03-27 | INGN | 6.19 | -90.9 | - | -0.52 |
| 2026-03-30 | INGN | 6.11 | -90.9 | - | -0.52 |
| 2026-03-31 | INGN | 6.19 | -90.9 | - | -0.52 |
| 2026-04-01 | INGN | 6.26 | -90.9 | - | -0.52 |
| 2026-04-02 | INGN | 6.20 | -90.9 | - | -0.52 |
| 2026-04-06 | INGN | 6.37 | -90.9 | - | -0.52 |
| 2026-04-07 | INGN | 6.81 | -90.9 | - | -0.52 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | INGN | 0.00 | 3.31 | 4.06 |
| 2026-03-10 | INGN | 0.00 | 3.31 | 4.06 |
| 2026-03-11 | INGN | 0.00 | 3.31 | 5.05 |
| 2026-03-12 | INGN | 0.00 | 3.31 | 5.05 |
| 2026-03-13 | INGN | 0.00 | 3.31 | 5.05 |
| 2026-03-17 | INGN | 0.00 | 3.47 | 5.05 |
| 2026-03-18 | INGN | 0.00 | 3.47 | 5.05 |
| 2026-03-19 | INGN | 0.00 | 3.47 | 5.05 |
| 2026-03-20 | INGN | 0.00 | 3.47 | 5.05 |
| 2026-03-23 | INGN | 0.00 | 3.49 | 5.05 |
| 2026-03-24 | INGN | 0.00 | 3.49 | 5.05 |
| 2026-03-25 | INGN | 0.00 | 3.49 | 4.86 |
| 2026-03-26 | INGN | 0.00 | 3.49 | 4.86 |
| 2026-03-27 | INGN | 0.00 | 3.49 | 4.86 |
| 2026-03-30 | INGN | 0.00 | 3.49 | 4.86 |
| 2026-03-31 | INGN | 0.00 | 3.49 | 4.86 |
| 2026-04-01 | INGN | 0.00 | 3.49 | 4.86 |
| 2026-04-02 | INGN | 0.00 | 3.49 | 4.86 |
| 2026-04-06 | INGN | 0.00 | 3.55 | 4.86 |
| 2026-04-07 | INGN | 0.00 | 3.55 | 4.86 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.26
Avg. EPS Est. Current Quarter
-0.21
Avg. EPS Est. Next Quarter
-0.03
Insider Transactions
Institutional Transactions
3.55
Beta
1.63
Average Sales Estimate Current Quarter
82
Average Sales Estimate Next Quarter
97
Fair Value
Quality Score
39
Growth Score
36
Sentiment Score
7
Actual DrawDown %
91.7
Max Drawdown 5-Year %
-94.9
Target Price
12.67
P/E
Forward P/E
PEG
P/S
0.53
P/B
0.96
P/Free Cash Flow
EPS
-0.86
Average EPS Est. Cur. Y
-0.52
EPS Next Y. (Est.)
-0.31
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-6.52
Relative Volume
2.24
Return on Equity vs Sector %
-39.3
Return on Equity vs Industry %
-23.7
EPS 1 7Days Diff
-0.4
EPS 1 30Days Diff
-0.36
EBIT Estimation
◆
INGN
Healthcare
$6.80
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
64.6
Range 1M
96.8%
Sup Dist
9.1%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
9.3%
EPS NY
37.6%
52W%
37.7%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+86.3% upside
Upside
+86.3%
Quality
39
Inogen, IncSector: Healthcare
Industry: Medical Devices
Employees: 753
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
INGN
Latest News
—
Caricamento notizie per INGN…
stock quote shares INGN – Inogen Inc. Stock Price stock today
news today INGN – Inogen Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch INGN – Inogen Inc. yahoo finance google finance
stock history INGN – Inogen Inc. invest stock market
stock prices INGN premarket after hours
ticker INGN fair value insiders trading